NSRX CIK: 2029039

Nasus Pharma Ltd

  • Israel
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25

Assets

(positive)
Change from FY24 to FY25
millions USD
FY24:
0.46
FY25:
4.86
(positive)
Change from FY24 to FY25
millions USD
FY24:
0.26
FY25:
0.15
Total assets
Change from FY24 to FY25
millions USD
FY24:
0.72
FY25:
5.00

Liabilities & Equity

(negative)
Change from FY24 to FY25
millions USD
FY24:
3.93
FY25:
2.16
(negative)
millions USD
FY24:
0
FY25:
0.07
(positive)
Change from FY24 to FY25
millions USD
FY24:
−3.21
FY25:
2.77
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY24:
0.72
FY25:
5.00

All amounts in millions USD Data source:SEC EDGAR